Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders

Abhilash Venugopal, Raghothama Chaerkady, Akhilesh Pandey

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Mass spectrometry-based quantitative proteomics has emerged as a powerful approach that has the potential to accelerate biomarker discovery, both for diagnostic as well as therapeutic purposes. Proteomics has traditionally been synonymous with 2D gels but is increasingly shifting to the use of gel-free systems and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Quantitative proteomic approaches have already been applied to investigate various neurological disorders, especially in the context of identifying biomarkers from cerebrospinal fluid and serum. This review highlights the scope of different applications of quantitative proteomics in understanding neurological disorders with special emphasis on biomarker discovery.

Original languageEnglish (US)
Pages (from-to)3-11
Number of pages9
JournalAnnals of Indian Academy of Neurology
Volume12
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

Fingerprint

Nervous System Diseases
Proteomics
Mass Spectrometry
Biomarkers
Gels
Tandem Mass Spectrometry
Liquid Chromatography
Cerebrospinal Fluid
Serum
Therapeutics

Keywords

  • Biomarkers
  • Diagnosis
  • Isotope labeling
  • Mass spectrometry

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders. / Venugopal, Abhilash; Chaerkady, Raghothama; Pandey, Akhilesh.

In: Annals of Indian Academy of Neurology, Vol. 12, No. 1, 01.01.2009, p. 3-11.

Research output: Contribution to journalReview article

@article{6f6686f7c6a04bd2b05c856ccfe922dc,
title = "Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders",
abstract = "Mass spectrometry-based quantitative proteomics has emerged as a powerful approach that has the potential to accelerate biomarker discovery, both for diagnostic as well as therapeutic purposes. Proteomics has traditionally been synonymous with 2D gels but is increasingly shifting to the use of gel-free systems and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Quantitative proteomic approaches have already been applied to investigate various neurological disorders, especially in the context of identifying biomarkers from cerebrospinal fluid and serum. This review highlights the scope of different applications of quantitative proteomics in understanding neurological disorders with special emphasis on biomarker discovery.",
keywords = "Biomarkers, Diagnosis, Isotope labeling, Mass spectrometry",
author = "Abhilash Venugopal and Raghothama Chaerkady and Akhilesh Pandey",
year = "2009",
month = "1",
day = "1",
doi = "10.4103/0972-2327.48845",
language = "English (US)",
volume = "12",
pages = "3--11",
journal = "Annals of Indian Academy of Neurology",
issn = "0972-2327",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders

AU - Venugopal, Abhilash

AU - Chaerkady, Raghothama

AU - Pandey, Akhilesh

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Mass spectrometry-based quantitative proteomics has emerged as a powerful approach that has the potential to accelerate biomarker discovery, both for diagnostic as well as therapeutic purposes. Proteomics has traditionally been synonymous with 2D gels but is increasingly shifting to the use of gel-free systems and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Quantitative proteomic approaches have already been applied to investigate various neurological disorders, especially in the context of identifying biomarkers from cerebrospinal fluid and serum. This review highlights the scope of different applications of quantitative proteomics in understanding neurological disorders with special emphasis on biomarker discovery.

AB - Mass spectrometry-based quantitative proteomics has emerged as a powerful approach that has the potential to accelerate biomarker discovery, both for diagnostic as well as therapeutic purposes. Proteomics has traditionally been synonymous with 2D gels but is increasingly shifting to the use of gel-free systems and liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Quantitative proteomic approaches have already been applied to investigate various neurological disorders, especially in the context of identifying biomarkers from cerebrospinal fluid and serum. This review highlights the scope of different applications of quantitative proteomics in understanding neurological disorders with special emphasis on biomarker discovery.

KW - Biomarkers

KW - Diagnosis

KW - Isotope labeling

KW - Mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=64149095472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64149095472&partnerID=8YFLogxK

U2 - 10.4103/0972-2327.48845

DO - 10.4103/0972-2327.48845

M3 - Review article

C2 - 20151002

AN - SCOPUS:64149095472

VL - 12

SP - 3

EP - 11

JO - Annals of Indian Academy of Neurology

JF - Annals of Indian Academy of Neurology

SN - 0972-2327

IS - 1

ER -